2.0
Dec 31, 2012
Former employee, more than 10 years
Cambridge, MA
Recommend
CEO approval
Business Outlook
Pros
Some outstanding people there positioned the company where it is today. Current earnings and drugs coming to market were the result of great foresight from those individuals.
Cons
Current management is taking credit for their predecessors but underperforming now. Mismanagement and a reversion to failed practices from the past don't bode well for the long run. They speak a good game but practice taking the money and I bet they will run before the floor drops.